Prostamax
Prostamax (Prostate Peptide Bioregulator)
A peptide bioregulator derived from prostate tissue. Part of the Russian peptide bioregulator series. Supports prostate health and urological function.
Mechanism of Action
Prostamax modulates gene expression in prostate epithelial cells, supporting prostate function, reducing inflammation, and promoting prostate cell health. Used in Russia for benign prostatic hyperplasia and prostatitis.
Health Claims & Evidence
Supports prostate health and function
May reduce BPH symptoms
Anti-inflammatory effects in prostate tissue
Short-Term Effects
Potential improvements in urological symptoms.
Long-Term Effects
Theoretical prostate protection with repeated courses.
Side Effects
Extremely well-tolerated.
Contraindications
Use with caution with prostate cancer history.
This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.
Research Papers
Prostamax and prostate bioregulation
Khavinson et al. · Bulletin of Experimental Biology and Medicine · 2002
Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.
Related Peptides
Explore the research further
Our AI Research Advisor can help you explore the evidence on Prostamax and related peptides, and prepare an educational research summary.
Explore Research